SCHOTT Pharma AG & Co KgaA Q4 2025 Earnings Call Transcript - Thomson StreetEvents

SCHOTT Pharma AG & Co KgaA Q4 2025 Earnings Call Transcript

SCHOTT Pharma AG & Co KgaA Q4 2025 Earnings Call Transcript - Thomson StreetEvents
SCHOTT Pharma AG & Co KgaA Q4 2025 Earnings Call Transcript
Published Dec 11, 2025
15 pages (8764 words) — Published Dec 11, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of 1SXP.DE earnings conference call or presentation 11-Dec-25 10:00am GMT

  
Brief Excerpt:

...Good morning, ladies and gentlemen. Thank you for joining our earnings call for the fiscal year 2025. My name is Tobias Erfurth, and I'm Head of Investor Relations. It's my pleasure to guide you through today's call. With me in the room are our CEO, Andreas Reisse; and our CFO, Reinhard Mayer. Andreas will kick off by sharing the key business and financial highlights of SCHOTT Pharma in the fiscal year 2025. He will also provide an update on our growth strategy, including our achievements in innovation and expansion this year. Following this, Reinhard will take us through our financials. He will also present our financial guidance for the fiscal year 2026, while Andreas will comment on the new midterm guidance after 2026. As always, the presentation will be followed by a Q&A session. Before we begin, slide 2, I would like to remind all participants to take a moment to review our disclaimer. Please note that we walk -- as we talk about the fiscal year 2025, we are referring to the period...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Co KgaA
Ticker
1SXP.DE
Time
10:00am GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Giang Nguyen - CITI - Analyst : Hope you can hear me. Two questions from me, please. So the first one is, can you please provide more color around the expected or the unexpected lower glass syringe demand in fiscal '26? And would you be able to confirm that it is related to GLP-1 auto-injectors or which of the customers? And the follow-up is that key customer going to someone else for glass syringes. LSEG STREETEVENTS | www.lseg.com | Contact Us consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies. DECEMBER 11, 2025 / 10:00AM, 1SXP.DE - Q4 2025 SCHOTT Pharma AG & Co KgaA Earnings Call And then maybe I have one follow-up, but I'll just leave it there for now. We cannot disclose customer names because we have signed NDAs with all our customers -- our big customers. And that's something we have to respect. So therefore, we cannot tell you much more about that topic than that -- other than that, yes.

Question: Giang Nguyen - CITI - Analyst : Helpful. And just one clarification for me. So in your 2026 outlook remarks earlier, you said that DDS is slightly flat and polymer syringes also flat. Just wanted to check if that -- if I got that correctly, meaning that glass syringes is flat overall, including this customer decline.

Table Of Contents

SCHOTT Pharma AG & Co KgaA Q3 2025 Earnings Call Transcript – 2025-08-12 – US$ 54.00 – Edited Transcript of 1SXP.DE earnings conference call or presentation 12-Aug-25 9:00am GMT

SCHOTT Pharma AG & Co KgaA Q2 2025 Earnings Call Transcript – 2025-05-15 – US$ 54.00 – Edited Transcript of 1SXP.DE earnings conference call or presentation 15-May-25 9:00am GMT

SCHOTT Pharma AG & Co KgaA Q1 2025 Earnings Call Transcript – 2025-02-13 – US$ 54.00 – Edited Transcript of 1SXP.DE earnings conference call or presentation 13-Feb-25 10:00am GMT

SCHOTT Pharma AG & Co KgaA Q3 2024 Earnings Call Transcript – 2024-08-29 – US$ 54.00 – Edited Transcript of 1SXP.DE earnings conference call or presentation 29-Aug-24 9:00am GMT

SCHOTT Pharma AG & Co KgaA Q2 2024 Earnings Call Transcript – 2024-06-27 – US$ 54.00 – Edited Transcript of 1SXP.DE earnings conference call or presentation 27-Jun-24 9:00am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "SCHOTT Pharma AG & Co KgaA Q4 2025 Earnings Call Transcript" Dec 11, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2025-SCHOTT-Pharma-AG-Co-KgaA-Earnings-Call-T16596676>
  
APA:
Thomson StreetEvents. (2025). SCHOTT Pharma AG & Co KgaA Q4 2025 Earnings Call Transcript Dec 11, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2025-SCHOTT-Pharma-AG-Co-KgaA-Earnings-Call-T16596676>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.